Moderna Inc (XSWX:MRNA)
CHF 58.54 +0.73 (+1.26%) Market Cap: 25.61 Bil Enterprise Value: 22.45 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 62/100

Moderna Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 07:20PM GMT
Release Date Price: CHF37.02 (-5.37%)
Salveen Richter
Goldman Sachs Group Inc - Analyst

Good afternoon, everyone. Thank you so much for joining us.

It's my pleasure to introduce Moderna.

With us, we have Jamey Mock, CFO. Jamey, thanks for joining us.

Jamey Mock
Moderna Inc - Chief Financial Officer

Thanks for having me.

Questions & Answers

Salveen Richter
Goldman Sachs Group Inc - Analyst

To start here, maybe frame for us how you see the company positioned today.

There's been an evolution, I think, with regard to the growth outlook for the commercial business, with the COVID and combination flu plus COVID vaccines, where you've gone to the point, I think, here of returning to this positive revenue growth cycle.

You have an opportunity set with your late-stage pipeline. What are you most focused on, when you look at this, from a strategy and execution standpoint, as we head into second half and beyond?

Jamey Mock
Moderna Inc - Chief Financial Officer

Yeah.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot